Financials
- Market Capitalization 53.7 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.84
Relación precio/flujo de caja
772.44
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4261 | BYSI BeyondSpring, Inc. - Ordinary Shares | 1.33 USD | 0.00% | -20.83% | -16.88% | -40.09% | 54.69 M USD | ||
| 4267 | TIL Instil Bio, Inc. - Common Stock | 7.94 USD | +3.93% | +2.45% | -0.13% | -59.26% | 53.85 M USD | ||
| 4280 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.00 USD | -2.60% | -2.39% | +12.64% | +1150.00% | 52.04 M USD | ||
| 4292 | MCRB Seres Therapeutics, Inc. - Common Stock | 5.27 USD | -6.23% | -33.04% | -9.45% | -35.97% | 50.52 M USD |